Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies

Kidney International

Volumn 53, Issue 5, 1998, Pages 1209-1216

  Ruggenenti, Piero ^a,b   Perna, Annalisa ^a   Mosconi, Lidia ^a   Pisoni, Roberto ^a   Remuzzi, Giuseppe ^a  

^a OSPEDALI RIUNITI   (Italy)

^b MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

Blood pressure; Chronic nephropathy; Glomerular filtration rate; Injury; Progression of renal disease; Proteinuria; Survival

Indexed keywords

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PREDICTION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; STATISTICAL ANALYSIS; URINARY EXCRETION;

EID: 0031819895     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00874.x     Document Type: Article

References (32)

1. BRENNER BM, MEYER TW, HOSTETTER TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis. N Engl J Med 307:652-659, 1982
2. HOSTETTER TH, OLSON JL, RENNKE HG, VENKATACHALAM MA, BRENNER BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241:F85-F93, 1981
3. KLAHR S, SCHREINER G, ICHIKAWA I: The progression of renal disease. N Engl J Med 318:1657-1666, 1988
4. REMUZZI G, BERTANI T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38: 384-394, 1990
5. ANDERSON S, MEYER TW, RENNKE HG, BRENNER BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76:612-619, 1985
6. ZATZ R, DUNN R, MEYER TW, ANDERSON S, RENNKE HG, BRENNER BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
7. ANDERSON S, RENNKE HG, GARCIA DL, BRENNER BM: Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 36:526-536, 1989
8. EDDY AA. MCCULLOCH L, LIU E, ADAMS J: A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. Am J Pathol 138:1111-1123, 1991
9. MORT M, YAMASHITA H, NAKANISHI C, KUIZUMI K, MAKINO S, KISHIMOTO Y, HAYASHI Y: Proteinuria induced by transplantable rat pituitary tumor MtTSAS. Model for homologous protein-overload proteinuria. Lab Invest 54:636-644, 1986
10. MAGIL AB: Tubulointerstitial lesions in human membranous glomerulonephritis: Relationship to proteinuria. Am J Kidney 25:375-379, 1995
11. REMUZZI G: Abnormal protein traffic through the glomerular barrier induces proximal tubular cell dysfunction and causes renal injury. Curr Opin Nephrol Hypertens 4:339-342, 1995
12. REMUZZI G, RUGGENENTI P, BENIGNI A: Understanding the nature of renal disease progression. Kidney Int 51:2-15, 1997
13. ROSSING P, HOMMEL E, SMIDT UM, PARVING H: Inpact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 42:715-719, 1993
14. BREYER JA, BAIN RP, EVANS JK, NAHMAN NS, LEWIS EJ, COOPER M, MCGILL J, BERL T, THE COLLABORATIVE STUDY GROUP: Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. Kidney Int 50:1651-1658, 1996
15. ROSSING P, HOMMLE E, SMIDT UM, PARVING HH: Reduction in albuminuria predicts diminished progression in diabetic nephropathy. Kidney Int 45(Suppl 45):S145-S149, 1994
16. GANSEVOORT RT, SLUTER WJ, HEMMELDER MH, DE ZEEUW D, DE JONG PE: Antiproteinuric effect of blood-pressure-lowering agents: A meta-analysis of comparative trials. Nephrol Dial Transplant 10:1963-1974, 1995
17. BJORCK S, MULEC H, JOHNSEN SA, NORDEN G, AURELL M: Renal protective effect of enalapril in diabetic nephropathy. Brit Med J 304:339-343, 1992
18. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
19. REMUZZI A, PUNTORIERI S, BATTAGLIA C, BERTANI T, REMUZZI G: Angiotensin converting-enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 85:541-549, 1990
20. GRUPPO ITALIANO STUDI EPIDEMIOLOGICI IN NEFROLOGIA (GISEN): A long-term, randomized clinical trial to evaluate the effects of ramipril on the evolution of renal function in chronic nephropathies. J Nephrol 3:193-202, 1991
21. THE GISEN GROUP (GRUPPO ITALIANO STUDI EPIDEMIOLOGICI IN NEFROLOGIA): Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and progression to terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349:1857-1863, 1997
22. GASPARl F. PERICO N, RUGGENENTI P, MOSCONI L, AMUCHASTEGUI CS, GUERINI E, DAINA E, REMUZZI G: Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate in patients with normal or impaired renal function. J Am Soc Nephrol 6:1-7, 1995
23. PARVING HH, ANDERSEN AR, SMIDI UM, HOMMEL E, MATHIESEN ER, SVENDSEN PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Brit Med J 294:1443-1447, 1987
24. KENDALL KG, STUART A: The advanced theory of statistics, in Inference and Relationship (3rd ed, vol 2), London, Griffin, 1973, pp 323-324
25. DRAPER N, SMIMTH H: Applied Regression Analysis (2nd ed), New York, J. Wiley and Sons Inc., 1981
26. COX DR: Regression models and life-tables (with discussion). J Royal Stat Soc (Series B) 34:187-220, 1972
27. DIAMOND JR, KARNOVSKY MJ: A putative role of hypercholesterolemia in progressive glomerular injury. Ann Rev Med 43:83-92, 1992
28. PETERSON JC, ADLLER S, BURKART JM, GREENE T, HEBERT LA, HUNSICKER LG, KING AJ, KLAHR S, MASSRY SG, SEIFTER J FOR THE MODIFICATION OF DIET IN RENAL DISEASE (MDRD) STUDY GROUP: Blood pressure control, proteinuria, and the progression of renal disease. Ann Intern Med 123:754-762, 1995
29. MASCHIO G, ALBERTI D, JANIN G, LOCATELLI F, MANN JFE, MOTOLESE M, PONTICELLI C, RITZ E, ZUCCHELLI P, THE ANGIOTENSIN-CONVERTING-ENZYME INHIBITION IN PROGRESSIVE RENAL INSUFFICIENCY STUDY GROUP: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:934-945, 1996
30. WEIDMANN P, SCHNEIDER M, BOHLEN L: Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: An updated meta-analysis. Nephrol Dial Transplant 10(Suppl 9):39-45, 1995
31. KASISKE BL, KALIL RSN, JENNIE Z, LIAO M, KEANE WF: Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Intern Med 118:129-138, 1993
32. BOHLEN L, DE COURTEN M, WEIDMANN P: Comparative study of the effect of ACE-inhibitors and other antihypertensive agents on proteinuria in diabetic patients. Am J Hypertens 7:84S-92S, 1994